期刊
INDIAN JOURNAL OF NUCLEAR MEDICINE
卷 35, 期 3, 页码 226-228出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/ijnm.IJNM_58_20
关键词
Actinium-225 tetraazacyclododecanetetraacetic acid-octreotide; liver metastases; rectal neuroendocrine tumor; single-photon emission computed tomography; computed tomography
Somatostatin receptor-targeted alpha radionuclide therapies have been introduced including actinium-225 labeled tetraazacyclododecanetetraacetic acid-octreotide (Ac-225 DOTATATE) for advanced metastatic neuroendocrine tumors (NET). Very limited data are available on the posttherapy imaging using Ac-225 DOTATATE therapy in metastatic NET. We present Ac-225 single-photon emission computed tomography/computed tomography images of a 72-year-old patient diagnosed as a case of advanced rectal NET treated primarily with Ac-225 DOTATATE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据